VJOncology Podcast

In this episode, we are joined by Professor Ghassan Abou-Alfa of Memorial Sloan Kettering Cancer Center. Professor Abou-Alfa is a renowned expert in biliary tract cancer and will be sharing insights and updates from the ASCO GI Cancers Symposium 2023, including a discussion of the Phase II IMbrave 151 trial (NCT04677504). We will also hear an overview of the current state of clinical practice in t...

The San Antonio Breast Cancer Symposium (SABCS) 2022 took place on the 6-10th of December 2022 in San Antonio, TX. Leading experts in breast cancer came together to hear the latest clinical trial data and discuss how to improve care for patients with breast cancer. In this podcast, we hear from Sara Tolaney, MD, MPH, Sarah Sammons, MD, and Paolo Tarantino, MD, of Dana-Farber Cancer Institute, Bost...

January is Cervical Cancer Awareness month, so for this podcast, we’ve collected the latest updates from our interviews with leading experts in cervical cancer.    Dr Jamie Takayesu, MD, of the University of Michigan, Ann Arbor, MI, explains recent research into disparities in the assessment of sexual function of men and women undergoing radiotherapy for prostate cancer or cervical cancer. Profess...

In this podcast, we’ll be covering the latest updates on immune checkpoint inhibitor resistance for patients with non-small cell lung cancer (NSCLC). We’ll be hearing from Professor Benjamin Besse, MD, Gustave Roussy Institute, Villejuif, France, Dr Kishu Ranjan, PhD, Yale School of Medicine, New Haven, CT, and Dr Biagio Ricciuti, MD, Dana-Farber Cancer Institute, Boston, MA, about new development...

Breast cancer is one of the leading causes of cancer mortality, with incidence, pathology and clinical outcomes varying by geographical distribution as well as different racial and ethnic populations. Black, compared to White women with localized breast cancer have higher mortality and worse distant recurrence-free survival, which is often attributed to social determinants of health and higher pre...

Gastrointestinal (GI) cancers have a high incidence rate and is the leading cause of cancer-related mortality. Despite current combinational treatment strategies including chemotherapy, surgery, radiotherapy, and targeted therapies, survival rates remain markedly low for patients with advanced disease due to treatment resistance, rapid disease progression and metastasis, creating a strong urgency...

The ESMO Asia 2022 congress took place on the 2nd to the 4th of December in Singapore. We heard from experts across Asia and Europe as they discussed the latest updates in oncology in the Asia-Pacific region.   In this episode, we hear from Dr Tomohiro Matsuda on the epidemiology of rare cancers in Asia, Dr Avinash Khadela and Dr Annalisa Trama on how to improve outcomes for patients with head and...

A large proportion of patients with non-small cell lung cancer (NSCLC) have mutations in EGFR, making it a popular target for novel therapeutics. In this podcast, we hear from Prof. Charles Swanton, Dr Emilia Lim, Prof. Sanjay Popat, Dr Qing Zhou, Dr Hazel O’Sullivan, Dr Julia Rotow, and Dr Biagio Ricciuti, as they discuss some of the latest clinical trial data in this field, as well as perspectiv...

The UKONS Annual Conference took place on 11th and 12th November 2022 in Belfast, Ireland. Leading experts gave updates on the latest challenges in oncology nursing, with discussion around the conference theme ‘cancer care in the digital age’. In this podcast, we hear from UKONS President Mark Foulkes (Royal Berkshire NHS Foundation Trust) with an overview of the UKONS 2022 debate on in-person ver...

The 37th Annual Meeting of the Society for Immunotherapy in Cancer (SITC) took place on the 8th-12th of November 2022 in Boston, MA. Leading experts discussed practice-changing trial updates and the latest news in immune-oncology.   In this podcast, we hear from Prof. Judith Varner (University of California, San Diego, CA) on the combination of myeloid cell and T-cell targeting as an effective ant...

The ASTRO 2022 Annual Meeting took place on the 23-26th October 2022, in San Antonio, TX. Leading experts gave updates on clinical trials in radiotherapy, as well as discussing hot topics in the field. In this podcast, we hear from several experts in the field of radiotherapy as they update us on the biggest trials and points of discussion presented at ASTRO 2022, including results from the CALLA...

Head and neck squamous cell carcinoma (HNSCC) is the most prevalent form of head and neck cancer and is typically associated with tobacco use and the human papillomavirus (HPV). Whilst this form of cancer has historically been associated with poor prognosis, the advent of checkpoint inhibitors such as pembrolizumab has increased overall survival in patients with PD-L1–expressing HNSCC. In this pod...

With the advent of next-generation sequencing technologies, circulating tumor DNA (ctDNA) has now become an important player in the diagnosis, treatment, and management of breast cancer. In early breast cancer, the clearance of ctDNA is associated with improved pathological complete response following neoadjuvant therapy and may be important in treatment selection in patients with advanced disease...

The Immunotherapy of Cancer Conference (ITOC) 2022 brought together experts in the field of immuno-oncology to hear the latest findings and discuss how to advance oncology drug development and delivery. In this podcast, we hear from Prof. Mascha Binder (Martin-Luther-Universität Halle-Wittenberg, Halle, Germany) discussing whether it is beneficial to combine immunotherapy with chemotherapy and Pro...

The European Society for Medical Oncology Annual Meeting 2022 brought together thousands of experts in oncology to hear new data and discuss how to improve the diagnosis and treatment of patients with cancer. In this podcast, we hear from some of the leading experts in sarcoma, as they discuss the biggest trials and hot topics from the meeting. Tom Wei-Wu Chen (National Taiwan University Hospital,...

Following an exciting day at the ESMO 2022 meeting in Paris, France, leading gastrointestinal cancer experts get together to share their highlights. Join Geoffrey Ku and Sam Klempner as they dissect key updates in upper GI cancer. Topics covered include updates from DESTINYGastric-02 (NCT04014075) and MOONLIGHT (NCT03647969), as well as discussions on the optimal use of immunotherapy for patients...

The European Society for Medical Oncology (ESMO) Annual Meeting, showcased an array of updates in breast cancer care and management, including updates on pivotal trials in the early and metastatic breast cancer settings. In this podcast, we hear from leading experts, Elisa Agostinetto and Evandro de Azambuja (Jules Bordet, Brussels, Belgium) who discuss the latest advances in breast cancer from ES...

The European Society for Medical Oncology Annual Meeting 2022 brought together thousands of experts in oncology to hear new data and discuss how to improve the diagnosis and treatment of patients with cancer. In this podcast, we hear from some of the leading experts in colorectal cancer, as they discuss the biggest trials and hot topics from the meeting. Dr Sartore-Bianchi discusses overcoming acq...

The European Society for Medical Oncology Annual Meeting 2022 brought together thousands of experts in oncology to hear new data and discuss how to improve the diagnosis and treatment of patients with cancer.   In this podcast, we hear from some of the leading experts in breast cancer, as they discuss the biggest trials and hot topics from the meeting. Dr Elisa Agostinetto discusses three of the b...

Catch up on our highlights from Day 4 of ESMO 2022! We spoke to Toni Choueiri, Erika Hamilton, Jonathan Rosenberg, and Charles Swanton, among many more! Keep an eye on VJOncology for more interviews, podcasts, and roundtable discussions throughout the congress.

Catch up on our highlights from Day 3 of ESMO 2022! We spoke to Fabrice Andre, Fred Saad, and Solange Peters, among many more! Keep an eye on VJOncology for more interviews, podcasts, and roundtable discussions throughout the congress.

Catch up on our highlights from Day 2 of ESMO 2022! We spoke to Dirk Schadendorf, Bjorn Henning Gronberg, Oleg Gluz, and Shaheenah Dawood, among many more! Keep an eye on VJOncology for more interviews, podcasts, and roundtable discussions throughout the congress.

The Lung Cancer Sessions from VJOncology aim to provide interesting perspectives from leading experts on the big topics in lung cancer research. In this podcast, we hear from Lizza Hendricks of Maastricht University and Tiziana Vavala of the University of Turin as they discuss key updates from the IASLC World Congress on Lung Cancer in Vienna, Austria. Topics include the use of sotorasib in KRASG1...

Immunotherapy plays a vital role in the management of patients with advanced-stage melanoma, and more recently, adoptive cell therapies and cancer vaccines have shown to be viable, novel treatment approaches able to induce complete and durable remissions in patients with melanoma. In this exclusive podcast, VJOncology speaks to Allison Betof Warner, MD, PhD, from Memorial Sloan Kettering Cancer Ce...

The International Association for the Study of Lung Cancer (IASLC) held their World Congress in Lung Cancer (WCLC) in Vienna, Austria, on the 6-9th August 2022. The congress brought together leading experts in lung cancer from around the world, to hear practice-changing trial updates and discuss the best ways to improve care for patients.   In this podcast, we hear from Dr Rachel Murray of Leeds C...